[Chlamydia pneumoniae as an etiologic factor in disease of the respiratory tract].
The described recently species of Chlamydia pneumoniae is the subject of a large number of scientific reports. The majority of infections caused by this microorganism are asymptomatic. However, a lot of cases of symptomatic infections have been described with both mild and severe clinical course. Symptoms related to infection may affect both upper and lower parts of the respiratory tract and may be accompanied by disorders in other systems and organs. Reports on the influence of chronic inflammation by Chlamydia pneumoniae on the development of arteriosclerosis are still controversial. The effective drugs in the treatment of Chlamydia pneumoniae infections are macrolides and tetracyclines.
Nalepa
P
P
Oddziału Chorób Płuc 5 Wojskowego Szpitala Klinicznego w Krakowie.
D000328:Adult; D002648:Child; D002690:Chlamydia Infections / Q000175:diagnosis*; D016993:Chlamydophila pneumoniae / Q000302:isolation & purification*; D002908:Chronic Disease; D006801:Humans; D012141:Respiratory Tract Infections / Q000382:microbiology*; D012698:Serologic Tests
Chlamydia pneumoniae jako czynnik etiologiczny w chorobach układu oddechowego.